These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 20701359)
1. Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue. Semenyuk A; Darian E; Liu J; Majumdar A; Cuenoud B; Miller PS; Mackerell AD; Seidman MM Biochemistry; 2010 Sep; 49(36):7867-78. PubMed ID: 20701359 [TBL] [Abstract][Full Text] [Related]
2. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide. Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel TFOs bearing an abasic portion and their triplex forming ability with a DNA duplex containing a pyrimidine-gapped polypurine strand. Sato M; Moriguchi T; Shinozuka K Nucleic Acids Res Suppl; 2003; (3):141-2. PubMed ID: 14510420 [TBL] [Abstract][Full Text] [Related]
4. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus. Maldonado R; Filarsky M; Grummt I; Längst G RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118 [TBL] [Abstract][Full Text] [Related]
5. Triplex-induced recombination and repair in the pyrimidine motif. Kalish JM; Seidman MM; Weeks DL; Glazer PM Nucleic Acids Res; 2005; 33(11):3492-502. PubMed ID: 15961731 [TBL] [Abstract][Full Text] [Related]
6. Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide. Campbell MA; Miller PS J Biol Inorg Chem; 2009 Aug; 14(6):873-81. PubMed ID: 19350290 [TBL] [Abstract][Full Text] [Related]
8. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts. Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319 [TBL] [Abstract][Full Text] [Related]
9. Targeting neighbouring poly(purine.pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides. Xodo LE; Rathinavelan T; Quadrifoglio F; Manzini G; Yathindra N Eur J Biochem; 2001 Feb; 268(3):656-64. PubMed ID: 11168404 [TBL] [Abstract][Full Text] [Related]
10. Solution structure of an antiparallel purine motif triplex containing a T.CG pyrimidine base triple. Ji J; Hogan ME; Gao X Structure; 1996 Apr; 4(4):425-35. PubMed ID: 8740365 [TBL] [Abstract][Full Text] [Related]
11. Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides. Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM Biochemistry; 2002 Jun; 41(24):7716-24. PubMed ID: 12056903 [TBL] [Abstract][Full Text] [Related]
12. Pyrimidine motif triplexes containing polypurine RNA or DNA with oligo 2'-O-methyl or DNA triplex forming oligonucleotides. Beban M; Miller PS Biochim Biophys Acta; 2000 Jun; 1492(1):155-62. PubMed ID: 10858542 [TBL] [Abstract][Full Text] [Related]
14. Molecular recognition via triplex formation of mixed purine/pyrimidine DNA sequences using oligoTRIPs. Li JS; Chen FX; Shikiya R; Marky LA; Gold B J Am Chem Soc; 2005 Sep; 127(36):12657-65. PubMed ID: 16144414 [TBL] [Abstract][Full Text] [Related]
15. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. Chan PP; Lin M; Faruqi AF; Powell J; Seidman MM; Glazer PM J Biol Chem; 1999 Apr; 274(17):11541-8. PubMed ID: 10206960 [TBL] [Abstract][Full Text] [Related]
16. Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: strong sequence-specific recognition by 2',4'-bridged nucleic-acid-containing 2-pyridones under physiological conditions. Obika S; Hari Y; Sekiguchi M; Imanishi T Chemistry; 2002 Oct; 8(20):4796-802. PubMed ID: 12561120 [TBL] [Abstract][Full Text] [Related]
17. Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines. Xodo LE; Manzini G; Quadrifoglio F Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):477-88. PubMed ID: 9918112 [TBL] [Abstract][Full Text] [Related]
18. Extensive sugar modification improves triple helix forming oligonucleotide activity in vitro but reduces activity in vivo. Alam MR; Majumdar A; Thazhathveetil AK; Liu ST; Liu JL; Puri N; Cuenoud B; Sasaki S; Miller PS; Seidman MM Biochemistry; 2007 Sep; 46(35):10222-33. PubMed ID: 17691818 [TBL] [Abstract][Full Text] [Related]
19. Triple helix formation: binding avidity of acridine-conjugated AG motif third strands containing natural, modified and surrogate bases opposed to pyrimidine interruptions in a polypurine target. Orson FM; Klysik J; Bergstrom DE; Ward B; Glass GA; Hua P; Kinsey BM Nucleic Acids Res; 1999 Feb; 27(3):810-6. PubMed ID: 9889277 [TBL] [Abstract][Full Text] [Related]
20. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides. Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]